论文部分内容阅读
目的:探讨痰热清注射液在治疗社区获得性肺炎的疗效与价值。方法:本研究中将2011年6月至2015年5月期间,我院所收治的80例社区获得性肺炎患者纳入临床研究范畴,利用数字随机表方法分组,设置为对照组与观察组,各组患者均为40例。对照组应用阿奇霉素治疗,观察组应用痰热清注射液治疗。对比疗效与安全性。结果:两组患者经过为期1 w治疗后,观察组临床总有效率达到92.50%(37/40),对照组则为70.00%(28/40),观察组明显高于对照组,组间对比的差异显著,有统计学意义(P<0.05)。两组患者在用药治疗期间未见明显不良反应及副作用,未对治疗连续性构成影响。结论:利用痰热清注射液对社区获得性肺炎患者进行治疗的价值显著,疗效优于阿奇霉素,值得在临床中加以推广。
Objective: To investigate the efficacy and value of Tanreqing injection in the treatment of community-acquired pneumonia. Methods: From June 2011 to May 2015, 80 cases of community-acquired pneumonia admitted to our hospital were included in the clinical research category, and were divided into the control group and the observation group by using the digital random table method Group patients were 40 cases. The control group was treated with azithromycin and the observation group was treated with Tanreqing Injection. Comparison of efficacy and safety. Results: After 1 w treatment, the total effective rate of the observation group was 92.50% (37/40) and that of the control group was 70.00% (28/40), the observation group was significantly higher than that of the control group The difference was statistically significant (P <0.05). No significant adverse reactions and side effects were observed in the two groups during treatment, which did not affect the continuity of treatment. Conclusion: The value of Tanreqing Injection in treating patients with community-acquired pneumonia is significant, and the curative effect is better than that of azithromycin, which is worth to be promoted in clinic.